Market Briefing

Weekly Watched Assets — 2026-09-05

7 high-conviction US stocks identified from monthly sentiment analysis.

NFLX — Netflix, Inc.

1W -4.2% | 1M +5.5% | 3M -4.8% | YTD -14.0%

"high-conviction, structural shift in institutional sentiment"

Thesis: The investment thesis is exceptionally strong, anchored by Bill Ackman's high-conviction re-entry and a $27.1B buyback, signaling aggressive shareholder returns and a structural shift in institutional sentiment. The NFL streaming deal serves as a clear near-term catalyst, creating asymmetric risk/reward amid a contrarian recovery. Conviction: 98% (high)

CEG — Constellation Energy Corporation

1W +8.0% | 1M +12.9% | 3M +17.5% | YTD -18.0%

"massive structural opportunity for long-term investors"

Thesis: CEG presents a compelling, catalyst-driven opportunity with the DOE's $1 billion loan approval for the Crane Clean Energy Center, validating its role in America's nuclear renaissance. Strong momentum and institutional conviction around a deep value inflection support a structural re-rating. Conviction: 95% (high)

BWXT — BWX Technologies Inc. Common Stock

1W +3.1% | 1M -6.2% | 3M -15.1% | YTD -13.0%

"solidifying its role as a foundational enabler of the U.S. nuclear renaissance"

Thesis: BWXT is positioned as a foundational enabler of the U.S. nuclear renaissance with the Janus program by 2028 acting as a high-visibility, strategic catalyst. Despite near-term price weakness, the thesis emphasizes technological dominance and asymmetric risk/reward in a contrarian recovery setup. Conviction: 95% (high)

TLN — Talen Energy Corporation Common Stock

1W +7.1% | 1M -3.9% | 3M -13.1% | YTD -20.1%

"multi-bagger"

Thesis: TLN offers one of the highest upside potentials with a 55% gap to consensus price target, supported by hard contracted cash flows and a deep value inflection. The call for aggressive accumulation is backed by a clear margin of safety and structural re-rating potential despite recent underperformance. Conviction: 95% (high)

MTB — M&T Bank Corporation

1W +1.7% | 1M -4.2% | 3M +8.5% | YTD +20.0%

"intrinsic value estimated at $420 per share—39.7% above current levels"

Thesis: MTB is significantly undervalued with intrinsic value estimated 39.7% above current price, supported by a $5 billion buyback as a near-term catalyst. The thesis is strong but operates in a less dynamic sector, moderating momentum and re-rating speed despite clear asymmetric risk/reward. Conviction: 95% (high)

ROP — Roper Technologies, Inc.

1W -4.4% | 1M +3.2% | 3M +22.9% | YTD -5.8%

"Argus’s $450 target implies 25% upside, far exceeding the average 7.7%—a clear signal of market inefficiency and latent re-rating potential"

Thesis: ROP exhibits a severe disconnect between fundamentals and valuation, with Argus's $450 target implying 25% upside, highlighting market inefficiency. While the re-rating case is logical, the lack of a specific event catalyst beyond valuation makes timing less certain despite strong conviction language. Conviction: 95% (high)

AADX — Applied Aerospace & Defense

1W -2.8% | 1M -39.1% | 3M -26.3% | YTD -32.0%

"a significant re-rating opportunity if the market shifts focus from accounting noise to revenue and backlog momentum"

Thesis: AADX is framed as a re-rating opportunity based on a shift in market focus toward fundamentals and H2 2026 margin expansion, but the catalyst is distant and dependent on sentiment change rather than concrete near-term events. Price performance is deeply negative, increasing risk despite high stated conviction. Conviction: 93% (high)

Weekly Watched Assets — 2026-08-25

4 high-conviction US stocks identified from monthly sentiment analysis.

VST — Vistra Corp.

1W -7.2% | 1M -17.0% | 3M -17.4% | YTD -17.7%

"the single most transformative event"

Thesis: VST presents a high-conviction, catalyst-driven opportunity centered on the transformative Helix Digital Infrastructure JV with NVIDIA, KKR, and Kuwait Investment Authority, which represents a structural inflection point likely to trigger a re-rating. The stock is deeply mispriced relative to its new strategic trajectory, offering asymmetric risk/reward despite near-term price weakness. Conviction: 98% (high)

YUMC — Yum China Holdings, Inc.

1W +3.8% | 1M +12.7% | 3M +11.3% | YTD +2.8%

"structural shift is the most significant value unlock in the company’s strategic evolution"

Thesis: YUMC is undergoing a structural shift through full ownership of Pizza Hut China and rapid scaling of its high-margin Burger Bar concept, driving immediate margin benefits and vertical integration. The stock trades at a steep discount to intrinsic value with strong near-term momentum, reinforcing the re-rating potential. Conviction: 96% (high)

FMCC — Federal Home Loan Mortgage Corp

1W +0.5% | 1M +1.1% | 3M -11.2% | YTD -45.9%

"high-conviction contrarian opportunity with explosive upside potential"

Thesis: FMCC represents a deep value, contrarian play with explosive upside potential driven by Oksenholt Capital's valuation challenge, which could force a market re-evaluation of its entrenched assumptions. Despite strong conviction and asymmetric risk/reward, the stock faces persistent headwinds reflected in its weak price performance. Conviction: 96% (high)

TEL — TE Connectivity Ltd.

1W -6.5% | 1M +0.1% | 3M -2.6% | YTD -12.3%

"a potential mispricing anomaly that presents a rare, high-conviction opportunity with asymmetric upside"

Thesis: TEL appears mispriced due to overlooked fundamentals and an upcoming catalyst from CEO presentations at major investor conferences, potentially triggering a structural re-rating. However, recent price weakness and less transformative catalysts relative to peers reduce near-term conviction despite strong institutional accumulation signals. Conviction: 96% (high)

Weekly Watched Assets — 2026-08-15

6 high-conviction US stocks identified from monthly sentiment analysis.

TRMB — Trimble Inc.

1W -3.2% | 1M +10.9% | 3M +4.5% | YTD -26.5%

"representing one of the most compelling valuation mispricing opportunities in the software sector"

Thesis: Trimble presents a high-conviction turnaround story with a profound disconnect between fundamentals and price, supported by a strategic pivot toward capital efficiency and one of the most compelling valuation mispricings in the software sector. Recent margin expansion and operational clarity reinforce sustainable improvement. Conviction: 97% (high)

HL — Hecla Mining Company Common Stock

1W +9.0% | 1M +18.8% | 3M +4.2% | YTD -2.6%

"massive 1.2 million-ounce annual silver boost by 2027–2028"

Thesis: Hecla offers a transformative, silver price-linked dividend and a clear path to 1.2 million additional ounces of silver production by 2027–2028, unlocking massive unmined value. The combination of aggressive accumulation signals, fortress balance sheet, and near-term production ramp creates a rare asymmetric opportunity in the mining sector. Conviction: 96% (high)

ELAN — Elanco Animal Health Incorporated Common Stock

1W +7.0% | 1M -7.3% | 3M +19.2% | YTD +5.1%

"dangerous disconnect between price and value"

Thesis: Elanco is in a deep value inflection phase with a dangerous disconnect between price and intrinsic value, driven by strong fundamentals and a near-term FDA EUA catalyst with immediate commercial impact. The stock's contrarian recovery setup offers asymmetric risk/reward despite recent volatility. Conviction: 96% (high)

SLF — Sun Life Financial Inc.

1W -0.7% | 1M +0.1% | 3M +14.2% | YTD +32.1%

"high-conviction re-rating opportunity"

Thesis: Sun Life represents a high-conviction re-rating opportunity driven by execution on its Asia wealth platform rollout, a key catalyst for valuation expansion. While fundamentals are strong and undervaluation is evident, the thesis hinges on successful execution, introducing moderate timing risk. Conviction: 95% (high)

TEL — TE Connectivity Ltd.

1W -0.1% | 1M +7.4% | 3M +5.8% | YTD -6.6%

"strategic purchase of RAM Photonics"

Thesis: TE Connectivity's acquisition of RAM Photonics strengthens its AI and robotics positioning, with immediate earnings accretion and a pivotal CEO investor campaign in 2026 serving as a re-rating catalyst. However, the thesis depends on precise integration and growth reacceleration, adding execution risk. Conviction: 93% (high)

UMC — United Microelectronics Corporation

1W +2.3% | 1M -23.1% | 3M +13.3% | YTD +148.6%

"a game-changing technological breakthrough"

Thesis: UMC is undergoing a critical strategic pivot with a game-changing silicon photonics breakthrough and $2B in committed capex, positioning it for explosive upside if commercial traction accelerates. Despite strong YTD performance, recent one-month weakness and reliance on future re-rating make it the most speculative of the group. Conviction: 93% (high)

Weekly Watched Assets — 2026-08-05

7 high-conviction US stocks identified from monthly sentiment analysis.

NVT — nVent Electric plc

1W +14.5% | 1M +6.8% | 3M -5.8% | YTD +52.6%

"cementing its status as a high-conviction, execution-driven play in the AI infrastructure revolution"

Thesis: NVT is a structural beneficiary of the AI revolution with a $2.6B backlog and direct validation through a Nvidia partnership, creating a high-conviction, execution-driven investment opportunity. The combination of explosive short-term momentum and a clear, tangible catalyst in AI infrastructure demand provides exceptional risk/reward clarity. Conviction: 96% (high)

GFL — GFL Environmental Inc.

1W +7.4% | 1M +12.3% | 3M +15.6% | YTD -1.8%

"GFL Environmental confirmed as a takeover target by at least six private equity firms"

Thesis: GFL presents a near-term, high-probability catalyst with multiple private equity firms actively pursuing a takeover at a $50/share premium, supported by a formal strategic review process and CEO rollover commitment. The stock exhibits strong recent momentum, reflecting growing market awareness of this imminent event. Conviction: 96% (high)

IX — ORIX Corporation

1W +2.6% | 1M +3.0% | 3M +18.0% | YTD +36.5%

"uniquely poised for a significant re-rating"

Thesis: IX combines explosive earnings momentum with a 55.7% earnings estimate revision, positioning it for a significant re-rating driven by rare valuation-growth alignment. Institutional accumulation and strong YTD performance underscore growing conviction in its time-sensitive re-pricing potential. Conviction: 96% (high)

MGA — Magna International Inc.

1W +1.5% | 1M +11.7% | 3M +12.6% | YTD +30.1%

"front-runner in China’s electrified automotive supply chain"

Thesis: MGA is experiencing a strategic inflection point as a front-runner in China’s electrified automotive supply chain, validated by a major contract with Chery and aggressive guidance revisions. Despite solid fundamentals and upward momentum, sentiment lags, creating a high-conviction re-rating opportunity. Conviction: 96% (high)

EPD — Enterprise Products Partners L.P.

1W +0.1% | 1M +5.3% | 3M +3.0% | YTD +24.0%

"dangerous disconnect between operational excellence and market recognition"

Thesis: EPD is deeply undervalued despite operational excellence and record cash flow, with a near-term catalyst from the Seaway Pipeline surge due to SPR drawdowns. The structural re-rating case is strong, though momentum is more modest compared to top-ranked names. Conviction: 95% (high)

GFS — GlobalFoundries Inc. Ordinary Shares

1W +6.1% | 1M -25.5% | 3M -27.9% | YTD +41.3%

"asymmetric risk/reward"

Thesis: GFS is a high-conviction contrarian play trading at a deep discount despite a transformative government endorsement and potential for re-rating post-August 2026 earnings. However, weak recent momentum and a prolonged drawdown increase near-term risk despite favorable long-term catalysts. Conviction: 95% (high)

LYSDY — Lynas Rare Earths ADR

1W +5.9% | 1M -13.1% | 3M -25.8% | YTD +26.0%

"strategic enabler for Western decoupling from Chinese-dominated rare earth supply chains"

Thesis: LYSDY is a strategic enabler of Western rare earth supply independence, de-risked by a $96M U.S. government contract and commercial breakthroughs. However, persistent negative momentum and valuation headwinds despite fundamental progress suggest execution and sentiment risks remain elevated. Conviction: 96% (high)

Weekly Watched Assets — 2026-07-25

7 high-conviction US stocks identified from monthly sentiment analysis.

GWRE — Guidewire Software Inc. Common Stock

1W +nan% | 1M +nan% | 3M +nan% | YTD +nan%

"a textbook fire-sale opportunity"

Thesis: The investment thesis centers on a rare, time-sensitive contrarian opportunity driven by Russell index inclusion, which will trigger passive inflows, amid strong operational performance and extreme valuation mispricing. The combination of a clear catalyst and institutional-grade conviction language underscores a high-conviction, asymmetric risk/reward setup. Conviction: 98% (high)

URBN — Urban Outfitters Inc

1W +nan% | 1M +nan% | 3M +nan% | YTD +nan%

"highlighting a massive market mispricing of a high-conviction turnaround story with tangible execution and innovation"

Thesis: A high-conviction turnaround story is supported by a Goldman Sachs upgrade, a Zacks Strong Buy rank, and a forced selling catalyst from Russell 2000 removal despite record fundamentals. This creates a clear, time-sensitive mispricing with strong upside potential as sentiment catches up to performance. Conviction: 96% (high)

EXE — Expand Energy Corp

1W +nan% | 1M +nan% | 3M +nan% | YTD +nan%

"Howard Marks made a significant accumulation of EXE shares at depressed levels, a high-conviction contrarian move"

Thesis: Howard Marks' aggressive accumulation at depressed levels signals a high-conviction contrarian bet ahead of a potential structural re-rating, amplified by a post-earnings sell-off that defied strong fundamentals. The upcoming Q2 earnings event with high implied volatility presents a defined catalyst for reversion. Conviction: 96% (high)

NOW — ServiceNow, Inc.

1W +nan% | 1M +nan% | 3M +nan% | YTD +nan%

"creating a rare, asymmetric contrarian opportunity"

Thesis: A rare market disconnect is highlighted, with Guggenheim's Buy upgrade acting as a near-term re-rating catalyst, supported by structural tailwinds and deep value inflection. The thesis is strong but slightly less time-sensitive than top-ranked names. Conviction: 96% (high)

PKX — POSCO Holdings Inc.

1W +nan% | 1M +nan% | 3M +nan% | YTD +nan%

"decisive move into U.S. lithium processing and positioning PKX as a first-mover in next-generation extraction technology"

Thesis: A transformative pivot into lithium and next-gen materials creates a high-conviction asymmetric case, backed by tangible catalysts like the U.S. DLE plant launch and Argentina project bankability. However, geopolitical and commodity risks add complexity to the re-rating path. Conviction: 95% (high)

RELX — RELX PLC

1W +nan% | 1M +nan% | 3M +nan% | YTD +nan%

"aggressive buyback programme is likely to become a key catalyst, potentially unlocking over 70% total shareholder return over five years if sentiment improves"

Thesis: The £2.25 billion irrevocable buyback serves as a powerful, near-term re-rating catalyst, with potential for over 70% shareholder return if sentiment improves. The thesis is compelling but more dependent on sentiment shift than operational or index-driven catalysts. Conviction: 95% (high)

FIS — Fidelity National Information Services, Inc.

1W +nan% | 1M +nan% | 3M +nan% | YTD +nan%

"deep and unsustainable disconnect between fundamentals and valuation"

Thesis: Despite a strong competitive moat and record growth, FIS trades at a deep valuation discount, creating a contrarian opportunity. Catalysts like Project Keystone are promising but less precisely timed, reducing urgency compared to peers with imminent triggers. Conviction: 93% (high)

Weekly Watched Assets — 2026-07-15

10 high-conviction US stocks identified from monthly sentiment analysis.

LNG — Cheniere Energy, Inc.

1W +3.9% | 1M +9.8% | 3M +3.5% | YTD +34.6%

"multi-bagger"

Thesis: The investment thesis centers on a severe mispricing amid record fundamentals and a permanent global LNG supply shortfall, with the destruction of Qatari capacity acting as a high-impact, near-term catalyst. Institutional options activity and aggressive accumulation underscore a structural re-rating with multi-bagger potential. Conviction: 96% (high)

ADSK — Autodesk, Inc.

1W -3.0% | 1M +3.8% | 3M -14.0% | YTD -28.2%

"FactSet names ADSK the most undervalued stock in the S&P 500 with 68% upside potential"

Thesis: Anchored by FactSet naming ADSK the most undervalued stock in the S&P 500 with 68% upside, the thesis is amplified by the FTC clearance of the MaintainX acquisition, catalyzing a powerful re-rating in a high-conviction SaaS play. The asymmetric upside is time-sensitive and institutionally validated. Conviction: 96% (high)

ZTO — ZTO Express (Cayman) Inc.

1W +3.7% | 1M +5.3% | 3M -4.2% | YTD +13.8%

"a strategic masterstroke with high potential to ignite a re-rating"

Thesis: The $1.5 billion fully funded share repurchase is a rare, aggressive capital allocation move that signals deep undervaluation and acts as a direct catalyst for a structural re-rating. This strategic masterstroke is drawing institutional attention in an underperforming sector. Conviction: 96% (high)

HII — Huntington Ingalls Industries, Inc.

1W -3.3% | 1M -5.9% | 3M -29.4% | YTD -19.4%

"asymmetric risk/reward"

Thesis: A transformative contract win and the July 2026 manned-unmanned teaming unveiling provide long-term revenue visibility and a structural shift into high-margin logistics, creating asymmetric risk/reward. The DCF-derived $452 fair value highlights a deep valuation gap warranting aggressive accumulation. Conviction: 96% (high)

LDOS — Leidos Holdings, Inc.

1W -1.9% | 1M -12.5% | 3M -32.8% | YTD -41.6%

"one of the most egregious market mispricings in the S&P 500"

Thesis: Despite a selloff after earnings, operational excellence persists, creating one of the most egregious mispricings in the S&P 500. A sentiment shift is imminent, offering high asymmetric risk/reward for contrarian investors positioned ahead of the re-rating. Conviction: 96% (high)

MKC — McCormick & Company, Incorporated

1W +1.2% | 1M +8.9% | 3M +0.9% | YTD -20.0%

"high-conviction, institutional-grade deal"

Thesis: The potential Berkshire Hathaway $45B preferred investment in the Unilever reverse Morris Trust merger is a high-conviction, structural re-rating catalyst. This institutional-grade deal could unlock massive value if execution is validated, justifying aggressive accumulation. Conviction: 96% (high)

BEP — Brookfield Renewable Partners L.P.

1W -2.5% | 1M -6.4% | 3M -8.3% | YTD +17.6%

"material, government-backed catalyst"

Thesis: The $17.5 billion nuclear financing and Boralex acquisition represent material, government-backed catalysts driving immediate structural acceleration. The deep value inflection is supported by aggressive accumulation amid market underappreciation. Conviction: 95% (high)

NOC — Northrop Grumman Corporation

1W -3.7% | 1M -3.9% | 3M -21.8% | YTD -9.0%

"dangerous disconnect between fundamentals and market pricing"

Thesis: With the 2027 DFARS rare earth deadline and B-21 production ramp, NOC is poised for a contrarian recovery driven by long-term defense tailwinds. The dangerous disconnect between fundamentals and pricing creates a deep value inflection with asymmetric risk/reward. Conviction: 95% (high)

J — Jacobs Solutions Inc.

1W -0.8% | 1M +1.8% | 3M +1.9% | YTD -4.0%

"classic case of 'slow growth' mindset mispricing a transformation leader in a high-growth inflection era"

Thesis: A record $27B backlog and 1.4x book-to-bill reveal a stark disconnect between slow-growth perception and transformational execution. The shift toward high-margin, visible growth offers a deep value opportunity as sentiment corrects. Conviction: 95% (high)

DG — Dollar General Corporation

1W +4.1% | 1M +5.2% | 3M -0.7% | YTD -10.9%

"transformative move to build a digitally enabled convenience network"

Thesis: DG's $352M in Q1 capex and 1,370+ store remodels signal a transformative pivot to a digitally integrated convenience network, with the 200-day breakout signaling institutional interest. While momentum is improving, macro risks in retail create higher execution uncertainty. Conviction: 94% (high)

Weekly Watched Assets — 2026-07-05

14 high-conviction US stocks identified from monthly sentiment analysis.

TEAM — Atlassian Corp.

1W +12.3% | 1M -23.1% | 3M +22.8% | YTD -45.8%

"structural re-rating"

Thesis: The investment thesis centers on a deep value inflection driven by explosive earnings revisions, a Zacks Rank #1, and extreme undervaluation amid forced selling, creating a time-sensitive window for structural re-rating. Near-term catalysts including AI monetization and index reclassification provide clear upside visibility. Conviction: 98% (high)

GH — Guardant Health Inc. Common Stock

1W +17.5% | 1M +29.1% | 3M +79.0% | YTD +65.1%

"seismic leap"

Thesis: GH is positioned at a transformative regulatory and commercial inflection point, with national coverage determination and UnitedHealthcare's 100M+ patient expansion serving as high-impact catalysts. The stock's momentum reflects early institutional accumulation ahead of potential market-destabilizing growth. Conviction: 96% (high)

TTAN — ServiceTitan Inc. Class A Common Stock

1W +23.5% | 1M +4.4% | 3M +24.4% | YTD -22.9%

"one of the most extreme dislocations in the tech sector"

Thesis: TTAN trades at a 40.1% discount to intrinsic value despite a dominant AI-enabled platform and growing transaction data moat. Monetization of 'Karen' AI and real revenue traction create a rare non-disruptable platform narrative with asymmetric risk/reward. Conviction: 97% (high)

IX — ORIX Corporation

1W +1.5% | 1M +0.6% | 3M +30.1% | YTD +32.5%

"transformative capital return move that materially boosts per-share value"

Thesis: A JPY 250 billion buyback with share cancellation acts as a powerful near-term catalyst, signaling strong fundamental acceleration and U.S. integration. The deep value inflection is supported by extraordinary earnings revision momentum and institutional confidence. Conviction: 96% (high)

ROP — Roper Technologies, Inc.

1W +9.6% | 1M +8.2% | 3M +2.0% | YTD -16.0%

"one of the most powerful sentiment indicators in the sector this week"

Thesis: ROP presents a rare contrarian opportunity in the software/industrial space, driven by high-conviction insider activity, extreme undervaluation, and imminent regulatory catalysts. The potential for rapid re-rating is amplified by its immunology franchise's transformative potential. Conviction: 96% (high)

BSX — Boston Scientific Corporation

1W +2.1% | 1M -5.3% | 3M -28.1% | YTD -52.3%

"catastrophic disconnect between fundamentals and market sentiment"

Thesis: Despite a severe FDA recall overhang, BSX shows strong fundamentals and near-term catalysts including Penumbra's Thunderbolt clearance and MiRus SIEGEL TAVR development. The catastrophic disconnect between sentiment and fundamentals creates a multi-bagger contrarian recovery case. Conviction: 95% (high)

ELV — Elevance Health, Inc.

1W +7.9% | 1M +7.9% | 3M +39.5% | YTD +19.2%

"structural re-rating"

Thesis: Seth Klarman’s $373M investment and the CMS lawsuit serve as pivotal catalysts for a structural re-rating, validating ELV's strategic shift. Momentum is strong, and the deep value inflection supports a high-conviction, multi-bagger recovery thesis. Conviction: 95% (high)

NYT — New York Times Company (The) Common Stock

1W +7.7% | 1M -1.9% | 3M -13.8% | YTD +6.3%

"central beneficiary of AI-driven attention economy monetization"

Thesis: Berkshire Hathaway’s near-tripling of its stake provides institutional validation, while the landmark lawsuit against OpenAI and Microsoft unlocks transformative AI licensing revenue potential. The thesis combines low-risk accumulation with high-return optionality. Conviction: 95% (high)

PCT — PureCycle Technologies, Inc.

1W -3.7% | 1M -40.8% | 3M +40.4% | YTD -15.0%

"giving PCT a near-monopoly in a high-growth segment"

Thesis: PCT holds a near-monopoly in food-grade #5 plastic recycling, with NJDEP certification acting as a key commercial catalyst. The market’s indiscriminate selling has created a dangerous disconnect between execution and perception, offering contrarian upside. Conviction: 95% (high)

NBIX — Neurocrine Biosciences Inc. Common Stock

1W +6.1% | 1M +12.5% | 3M +32.4% | YTD +23.9%

"paradigm shift in pediatric endocrine therapy"

Thesis: NBIX is leveraging groundbreaking clinical results to build a rare sustainable revenue moat in pediatric endocrinology and rare diseases. The transformative foothold in congenital adrenal hyperplasia provides a clear path to blockbuster potential and investor confidence inflection. Conviction: 94% (high)

BWXT — BWX Technologies Inc. Common Stock

1W -6.7% | 1M +2.0% | 3M -11.0% | YTD +5.3%

"paradigm shift in BWXT’s business model"

Thesis: BWXT is undergoing a paradigm shift from parts supplier to technology enabler, fueled by the $1.4B DOE contract and mPower™ licensing, creating a high-margin, royalty-backed SMR growth engine. The deep valuation disconnect suggests significant re-rating potential. Conviction: 94% (high)

CTSH — Cognizant Technology Solutions Corporation

1W +7.2% | 1M -23.9% | 3M -32.4% | YTD -47.7%

"a credible move positioning CTSH as a first-mover in sovereign AI infrastructure"

Thesis: CTSH is emerging as a foundational enabler in the agentic AI era, with strategic partnerships and sovereign AI infrastructure positioning. Pzena’s stake increase during the selloff signals contrarian conviction in undervaluation and future re-rating. Conviction: 93% (high)

ZTO — ZTO Express (Cayman) Inc.

1W +5.9% | 1M +2.2% | 3M -6.0% | YTD +9.3%

"creating a high-conviction long-term value and growth opportunity"

Thesis: ZTO combines operational outperformance with a fully funded $1.5B buyback, creating a high-conviction long-term value opportunity despite sentiment weakness. The PEG of 0.84 highlights a severe fundamental-market disconnect. Conviction: 95% (high)

VST — Vistra Corp.

1W -10.0% | 1M -4.2% | 3M +0.1% | YTD -8.3%

"unquestioned infrastructure backbone of the AI era"

Thesis: VST is the unquestioned infrastructure backbone of the AI era, with transformative PPAs and exceptional ROE execution. Despite deep undervaluation, recent negative price momentum and lack of near-term momentum indicators reduce near-term conviction. Conviction: 92% (high)

Weekly Watched Assets — 2026-06-25

10 high-conviction US stocks identified from monthly sentiment analysis.

NTES — NetEase Inc. ADR

1W -2.7% | 1M +1.5% | 3M +7.6% | YTD -19.0%

"a rare high-conviction opportunity where fundamentals are outpacing sentiment, making any failure to meet expectations potentially catastrophic"

Thesis: NetEase presents a rare confluence of deep value, high-quality growth, and a near-term catalyst through its participation in DeepSeek's $7.4B funding round, which could trigger a structural re-rating. The market is underpricing both its fundamental strength and strategic AI positioning, creating asymmetric risk/reward. Conviction: 97% (high)

ROP — Roper Technologies, Inc.

1W +0.5% | 1M +1.4% | 3M -5.3% | YTD -23.5%

"one of the most compelling individual conviction signals in the software/industrial space"

Thesis: Roper combines exceptional capital allocation with a $3 billion buyback and insider buying, signaling strong internal confidence. The company is deeply undervalued despite durable cash flows, with mounting contrarian signals pointing to an imminent re-rating. Conviction: 97% (high)

IFF — International Flavors & Fragrances Inc.

1W +0.2% | 1M +1.3% | 3M +7.1% | YTD +12.7%

"deep value inflection"

Thesis: IFF is poised for a structural re-rating following the completion of its $4.3 billion divestiture, which unlocks significant margin of safety and enables aggressive accumulation. Insider buying and a major upgrade confirm a deep value inflection is underway. Conviction: 96% (high)

IX — ORIX Corporation

1W -3.2% | 1M -1.3% | 3M +29.4% | YTD +30.0%

"unmodeled Kioxia stake sale catalyst is critical: if Toshiba proceeds, ORIX’s earnings and valuation could rise sharply"

Thesis: ORIX offers a rare deep value opportunity in financials, driven by a JPY 250 billion buyback with share cancellations and a potential unmodeled catalyst from the Kioxia stake sale. These factors create significant per-share value accretion and asymmetric upside. Conviction: 96% (high)

J — Jacobs Solutions Inc.

1W -0.7% | 1M +6.4% | 3M -5.5% | YTD -9.3%

"fundamentally reshaping its strategic trajectory"

Thesis: Jacobs is fundamentally reshaping its trajectory with a record $26 billion+ backlog and near-monopoly access to key government programs. Despite operational excellence, it remains aggressively undervalued, creating explosive commercial momentum and a clear path to re-rating. Conviction: 94% (high)

RELX — RELX PLC

1W -2.7% | 1M -5.6% | 3M -1.0% | YTD -20.2%

"a stark market disconnect exposing a dangerous mispricing and systemic overreaction to narrative risk, not substance"

Thesis: RELX is experiencing a severe market disconnect despite being a core enabler of AI through its partnership with Anthropic. The mispricing creates a rare long-term compounding opportunity with asymmetric risk/reward and strong contrarian tailwinds. Conviction: 95% (high)

PTC — PTC Inc.

1W -3.4% | 1M -23.8% | 3M -21.6% | YTD -33.6%

"deeply undervalued business with rare profitability and scalability"

Thesis: PTC is transforming legacy systems into intelligent digital engineering platforms, supported by a $2 billion buyback and strong AI integration. Despite transient sentiment drag, its profitability and scalability are deeply undervalued, signaling a potential inflection. Conviction: 95% (high)

VG — Venture Global Inc. Class A common stock

1W -4.9% | 1M -23.9% | 3M -37.4% | YTD +49.7%

"breakthrough in U.S. LNG export momentum"

Thesis: Venture Global has achieved a breakthrough in U.S. LNG export momentum with landmark deals and a $2.25B refinancing, providing exceptional revenue visibility. The market has yet to price in this institutional-grade credibility and infrastructure scaling. Conviction: 95% (high)

VRSN — VeriSign, Inc.

1W -4.8% | 1M -18.7% | 3M +0.8% | YTD +5.5%

"high-conviction bet on a sustained move above $290"

Thesis: VeriSign is positioned for a structural re-rating around the $290 options expiration, supported by concentrated institutional call buying. Persistent underreaction to fundamentals creates a time-sensitive, high-conviction setup despite near-term volatility. Conviction: 95% (high)

ONDS — Ondas Holdings Inc

1W -15.8% | 1M -15.2% | 3M -18.6% | YTD -30.3%

"a defining inflection point for the company"

Thesis: Ondas is at a defining inflection point with U.S. Army contract integration and Lockheed Martin’s Sanctum™ adoption, but faces significant execution risk and negative momentum. While the long-term vision is compelling, near-term uncertainty dampens risk/reward clarity. Conviction: 94% (high)

Weekly Watched Assets — 2026-06-15

8 high-conviction US stocks identified from monthly sentiment analysis.

AES — The AES Corporation

1W +0.1% | 1M +1.7% | 3M +4.7% | YTD +1.5%

"ironclad arbitrage case with minimal execution risk"

Thesis: The investment thesis is centered on a near-certain, low-risk arbitrage opportunity with a $15.00 all-cash acquisition offer, trading below offer price with minimal execution risk. This represents one of the clearest risk/reward profiles with a defined catalyst and time horizon. Conviction: 96% (high)

NTES — NetEase Inc. ADR

1W +5.3% | 1M +5.6% | 3M +8.8% | YTD -13.4%

"high-conviction, asymmetric opportunity"

Thesis: A high-conviction, asymmetric opportunity driven by AI integration and a strategic stake in DeepSeek, creating a clear catalyst for re-rating amid substantial undervaluation. The thesis is tightly coupled with tangible, near-term value realization potential. Conviction: 98% (high)

RNR — RenaissanceRe Holdings Ltd.

1W +4.3% | 1M +3.8% | 3M +2.4% | YTD +10.7%

"significant mispricing risk and high-conviction contrarian opportunity"

Thesis: Exhibits a compelling contrarian case with severe undervaluation relative to earnings power and capital efficiency, supported by a structural re-rating catalyst from improved underwriting performance and capital returns. Momentum is building, and risk/reward is clearly skewed to the upside. Conviction: 98% (high)

ROP — Roper Technologies, Inc.

1W +0.8% | 1M +5.9% | 3M -4.3% | YTD -22.7%

"transformative capital allocation strategy"

Thesis: A high-conviction value bet anchored in a transformative $3 billion buyback, signaling deep undervaluation and strong internal confidence in future cash flows. The thesis is reinforced by a rare combination of capital allocation clarity and long-term structural advantages. Conviction: 96% (high)

BKNG — Booking Holdings Inc.

1W -0.5% | 1M +6.7% | 3M -2.5% | YTD -22.2%

"a powerful leap beyond traditional booking platforms into AI-native travel intelligence"

Thesis: Despite negative YTD performance, the thesis highlights a rare sentiment-driven mispricing amid strong operational resilience and a powerful AI-driven transformation via Penny launch and board-level strategic shifts. Catalysts are specific but longer-term, with re-rating potential delayed by macro sentiment. Conviction: 96% (high)

SUZ — Suzano S.A.

1W +0.6% | 1M -4.0% | 3M -17.8% | YTD -13.5%

"structural redefinition of the company"

Thesis: Presents a high-conviction, asymmetrical opportunity driven by a structural redefinition through a transformative joint venture with Kimberly-Clark, yet trading at extreme discount levels. Catalyst is sentiment re-rating, which is specific but dependent on market perception shifts. Conviction: 96% (high)

HAWK — HawkEye 360

1W -5.5% | 1M -29.3% | 3M n/a | YTD -30.0%

"a make-or-break inflection point for HAWK’s long-term viability"

Thesis: A speculative but high-upside inflection play hinging on the Block 3 satellite deployment as a make-or-break catalyst. While the valuation disconnect and asymmetric risk/reward are clearly articulated, the thesis carries high execution risk and weak recent momentum, increasing uncertainty. Conviction: 96% (high)

MDGL — Madrigal Pharmaceuticals Inc. Common Stock

1W -1.3% | 1M -7.3% | 3M +8.1% | YTD -19.0%

"powerful asymmetric opportunity"

Thesis: Represents a high-risk, high-reward biotech play dependent on F4c trial outcomes, with explosive commercial potential but significant binary risk. Despite strong conviction language, lack of positive momentum and high volatility reduce near-term appeal despite the asymmetric profile. Conviction: 95% (high)

Weekly Watched Assets — 2026-06-05

15 high-conviction US stocks identified from monthly sentiment analysis.

MTCH — Match Group, Inc.

1W -4.4% | 1M -7.7% | 3M +11.7% | YTD +10.8%

"presenting a high-conviction, asymmetric opportunity"

Thesis: The CCI ruling serves as a near-term, high-likelihood catalyst enabling massive structural margin expansion, creating a rare asymmetric opportunity with deep undervaluation relative to DCF. The investment thesis is tightly coupled with a clear, binary catalyst and aggressive accumulation language. Conviction: 97% (high)

ROP — Roper Technologies, Inc.

1W +3.8% | 1M -6.9% | 3M -9.1% | YTD -23.4%

"nearly 38% below fair value"

Thesis: With a nearly 38% undervaluation to fair value and multiple catalysts including transformative regulatory approval and aggressive capital return, ROP presents a high-conviction, structural re-rating opportunity. The thesis is backed by exceptional fundamentals and institutional endorsement. Conviction: 98% (high)

NTRA — Natera Inc. Common Stock

1W +3.8% | 1M +7.4% | 3M +12.7% | YTD -3.0%

"paradigm-shifting event"

Thesis: FDA approval of Signatera CDx is a paradigm-shifting, reimbursement-enabling catalyst that validates NTRA's shift from speculative growth to earnings-based confidence. Extreme valuation disconnect and aggressive price target upgrades signal substantial unpriced upside. Conviction: 96% (high)

PODD — Insulet Corporation

1W +2.6% | 1M -12.6% | 3M -39.2% | YTD -48.2%

"multi-bagger"

Thesis: Despite a severe drawdown, PODD shows deep institutional faith and a clear path to recovery via FDA approval for Omnipod 6 enabled by Libre 3 Plus integration, framing it as a contrarian multi-bagger opportunity with significant margin of safety. Conviction: 96% (high)

WDAY — Workday Inc.

1W +13.8% | 1M +14.8% | 3M +0.5% | YTD -28.1%

"quantum leap in trust and governance"

Thesis: ASOR certification and AI leadership represent a quantum leap in governance and trust, exposing a dangerous disconnect between fundamentals and price. The structural re-rating case is time-sensitive and supported by strong momentum in the past month. Conviction: 96% (high)

DHR — Danaher Corporation

1W +3.3% | 1M +6.9% | 3M -7.4% | YTD -18.8%

"aggressive move into AI-native bioprocessing (Genedata Vico) and precision oncology ecosystems gives it a first-mover advantage"

Thesis: The Masimo acquisition is central to DHR’s long-term AI-driven biopharma narrative and highlights a severe mispricing despite operational resilience and science-tech convergence. The 33.1x P/E belies stagnation fears amid underlying innovation. Conviction: 95% (high)

A — Agilent Technologies, Inc.

1W +2.2% | 1M +17.7% | 3M +17.4% | YTD +0.7%

"transformative shift toward an AI-powered, recurring-revenue intelligent laboratory ecosystem with outsized long-term growth potential"

Thesis: Agilent is transitioning into an AI-powered, recurring-revenue intelligent lab ecosystem with a structural moat in precision oncology, driven by FDA milestones and pent-up investor demand. The re-rating potential is amplified by execution confidence. Conviction: 95% (high)

BEPC — Brookfield Renewable Corporation Brookfield Renewable Corporation Class A Subordinate Voting Shares

1W -1.6% | 1M +6.9% | 3M -2.4% | YTD -0.8%

"asymmetric risk/reward"

Thesis: The Microsoft 10.5 GW deal provides a concrete near-term catalyst for a deep value inflection, with aggressive accumulation signaling institutional conviction in a structural re-rating despite short-term underperformance. Conviction: 95% (high)

EXR — Extra Space Storage Inc.

1W +0.0% | 1M +4.3% | 3M +0.0% | YTD +12.7%

"redefine the self-storage sector’s technological future"

Thesis: The appointment of RJ Pittman signals a transformational AI-driven pivot that could redefine the self-storage sector, creating a high-conviction, deep value inflection with a significant margin of safety. Conviction: 96% (high)

NTRS — Northern Trust Corporation

1W +2.8% | 1M +7.1% | 3M +21.3% | YTD +24.9%

"highlighting a clear market mispricing of its capital efficiency and sustainable growth profile"

Thesis: NTRS is undergoing a decisive shift into quant and smart beta asset management, with a clear market mispricing of its capital efficiency and growth profile. Strong 3-month and YTD performance validate the emerging re-rating. Conviction: 94% (high)

WPC — W. P. Carey Inc.

1W -0.3% | 1M +1.1% | 3M +3.3% | YTD +15.6%

"glaring mispricing"

Thesis: The $1.1B GardenCore sale-leaseback is a strategic inflection point that demonstrates unmatched capital deployment and earnings visibility, with institutional validation and aggressive accumulation underscoring a glaring mispricing. Conviction: 95% (high)

RMD — ResMed Inc.

1W -4.5% | 1M -6.2% | 3M -23.7% | YTD -20.2%

"profound valuation disconnect"

Thesis: Despite an unexplained 8.81% decline amid sector strength, RMD’s pivot into digital therapeutics via Noctrix and ŪRA partnership reveals a profound valuation disconnect and transformative clinical pipeline potential. Conviction: 96% (high)

XOM — Exxon Mobil Corporation

1W +3.5% | 1M -1.2% | 3M +1.5% | YTD +25.6%

"transforming Guyana into a self-sustaining, high-margin growth engine"

Thesis: Exxon’s transformation in Guyana and governance improvements are de-risking long-standing overhangs, positioning as investor skepticism sets up a powerful re-rating catalyst amid energy security tailwinds. Conviction: 95% (high)

SEIC — SEI Investments Company Common Stock

1W -0.0% | 1M -2.4% | 3M +8.0% | YTD +6.7%

"a compelling mispricing opportunity if execution holds"

Thesis: SEI’s launch of SEHAX and LEND ETFs and the Stratos acquisition mark a strategic inflection toward active management, disrupting low-cost ETF models—though execution risk remains a caveat despite compelling mispricing. Conviction: 95% (high)

TS — Tenaris S.A.

1W +6.5% | 1M +2.7% | 3M +23.7% | YTD +66.8%

"presents a rare opportunity for value investors"

Thesis: Despite strong fundamentals and capital returns, Tenaris experienced a post-earnings sell-off, creating a rare value opportunity. However, the thesis lacks depth compared to peers, with fewer specific growth catalysts beyond market mispricing. Conviction: 92% (high)